Capricor Therapeutics Inc (NASDAQ:CAPR)
| 3.43 Delayed Data As of 10:31am ET |  -2.37 / -40.86%Today’s Change | 3.30 Today|||52-Week Range 8.22 | -11.14% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Operating Activities | Net Income / Starting Line | -4.1M | -3.3M | -2.5M | -2.0M | |
| Depreciation | 41.4K | 43.3K | 43.3K | 43.1K | ||
| Total Other Cash Flow | 430.4K | 390.8K | 223.2K | 126.9K | ||
| Funds From Operations | -3.7M | -2.8M | -2.3M | -1.9M | ||
| Funds From/For Other Operating Expenses | -682.3K | 945.4K | -645.2K | -99.0K | ||
| Net Cash Flow - Operating Activities | -3.0M | -3.8M | -1.6M | -1.8M | ||
| Investing | Increase In Investments | -6.0M | -3.0M | -15.2K | 0.00 | |
| Decrease In Investments | 6.0M | 6.0M | 3.0M | 0.00 | ||
| Capital Expenditures | -145.5K | 15.6K | 0.00 | 0.00 | ||
| Net Cash Flow Investing | -142.6K | 3.0M | 3.0M | 0.00 | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 1.1M | 512.0K | 1.4M | 545.9K | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | -193.00 | ||
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 1.1M | 512.1K | 1.4M | 545.7K | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -2.1M | -254.4K | 2.8M | -1.2M | ||
